Reversal of Anticoagulation: Protamine

Bengt Lindblad, Jan Holst

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Original languageEnglish
Title of host publicationPharmacology in the Catheterization Laboratory
EditorsRon Waksman, Andrew E. Ajani
PublisherWiley-Blackwell
Pages287-293
ISBN (Electronic)9781444306347
ISBN (Print)9781405157049
DOIs
Publication statusPublished - 2009 Oct 30

Subject classification (UKÄ)

  • Cardiology and Cardiovascular Disease

Free keywords

  • Haemodynamic adverse response to protamine reversal of anticoagulation
  • Low-molecular-weight heparins (LMWH) as anticoagulant agents
  • Mechanism of action-reversal of heparinization
  • Monitoring neutralizing effect of protamine
  • New pharmacological agents-direct thrombin inhibitors and factor Xa inhibitors
  • Nonimmunological reactions-cell-membrane interactions and cascade systems interactions
  • Reversal of anticoagulation-protamine
  • Tissue factor pathway inhibitor (TFPI)
  • Type I and III immunological reactions and Coombs and Gell's classification
  • Unfractionated heparin (UH)-substance of choice minimizing risk of thrombotic complications

Cite this